At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
No treatmentother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Cerebrospinal Fluid Collection Study in Pediatric and Adult Patients With Hunter Syndrome
In Brief
An observational study evaluating No treatment for Hunter Syndrome. Completed, enrolled 10 participants across 7 sites in 2 countries.
Detailed Summary
The purpose of the study is to collect data on CSF biomarkers in patients with Hunter Syndrome that would serve as reference data for comparison with cognitively impaired patients with Hunter syndrome, patients with other lysosomal storage diseases, or other diseases with CNS involvement.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHunter Syndrome
CountriesUnited Kingdom, United States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedOct 2011
Enrollment StartNov 2012
Primary CompletionDec 2013
TodayJul 2026
First PostedOct 10, 2011
Enrollment StartNov 12, 2012
Primary CompletionDec 20, 2013
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 14.7 years ago
Interventions
No treatmentother